Skip to content

Effects of the Breath Stacking Technique After Upper Abdominal Surgery

Effects of the Breath Stacking Technique After Upper Abdominal Surgery: Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04418700
Enrollment
32
Registered
2020-06-05
Start date
2020-06-01
Completion date
2021-03-31
Last updated
2021-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abdominal Surgery

Keywords

surgery, abdomen, pulmonary ventilation, physical therapy techniques

Brief summary

This study evaluates the effects of the breath stacking technique in patients after upper abdominal surgery. Half of the patients receive routine physical therapy associated with the Breath Stacking technique, while the other half will receive only routine physical therapy.

Detailed description

This randomized controlled study aims to evaluate the effects of the Breath Stacking technique in patients undergoing upper abdominal surgery on clinical, physiological and cardiopulmonary variables. These individuals were randomized to compose the control group (CG) and the intervention group (GBS). The routine physical therapy was performed in both groups and in the GBS two daily sessions of up to 20 minutes of Breath Stacking technique were applied. To verify the effect of this intervention, before and after the protocol, patients underwent the following evaluations: algometry, cirtometry in the axillary line , umbilical line and the xiphoid process, ventilometry, spirometry and manovacuometry.

Interventions

The patients will perform the maneuver through successive inspiratory efforts for 20 s. Subsequently, the expiratory branch will be unobstructed to allow expiration. This maneuver will be repeated 5 times in each series, with intervals of 30 seconds between them. The technique will be performed with the trunk inclined 30º in relation to the horizontal plane, in 3 series, with interval of 2 min completing 15 min of therapy.

Sponsors

Universidade Federal de Santa Maria
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Patients undergoing a surgical procedure that involves in an incision in the upper quadrants of the abdominal region.

Exclusion criteria

* Intolerance to the use of BS mask. * Chronic obstructive pulmonary disease (COPD), Asthma, Chron's disease. * Liver trauma severe with hemodynamic repercussions. * Patients undergoing esophagectomy. * Sepsis with complications postoperative hemodynamics. * Need for surgical reintervention. * Forwarded to Intensive Care Unit or need for mechanical ventilation after discharge from the anesthetic recovery. * Cognitive dysfunction that makes it impossible to understand and execute evaluations and intervention.

Design outcomes

Primary

MeasureTime frameDescription
Change from second postoperative day forced vital capacity (FVC) at 7th postoperative day or hospital discharge.The change in FVC will be evaluated on the 2nd postoperative day and up to 7th postoperative day.The FVC will be evaluated as recommended by the American Thoracic Society and European Respiratory Society (2006) and based on reproducibility and acceptability criteria, three maneuvers will be performed (variability \<5%) and considered the best curve for the study.
Change from second postoperative day tidal volume at 7th postoperative day or hospital discharge.The change in tidal volume will be evaluated on the 2nd postoperative day and up to 7th postoperative day.Tidal volume will be obtained through the division of the minute volume by the respiratory rate.

Secondary

MeasureTime frameDescription
Blood pressureThese will be evaluated on the 2nd postoperative day and up to 7th postoperative day. These will also be measured before and after the first and last BS session.Systolic and diastolic blood pressure will be verified by a stethoscope and sphygmomanometer.
Peripheral oxygen saturation (SpO2)It will be evaluated on the 2nd postoperative day and up to 7th postoperative day. This variable will also be measured before and after the first and last BS session.It will be evaluated with portable pulse oximeter.
Painful perception in the surgical incisionIt will be evaluated on the 2nd postoperative day and up to 7th postoperative day.The digital algometer will be used, which constitutes a dynamometer that exerts pressure with a rubber tip 1 cm in diameter on the skin, at a 90º angle, determining the pain threshold.
Thoracoabdominal mobilityIt will be evaluated on the 2nd postoperative day and up to 7th postoperative day.The measuring tape will be positioned in three anatomical points: axillary fold, xiphoid appendix and umbilical line. The measurements will be performed at rest, after maximum inspiration and after maximum expiration.
Minute volumeIt will be evaluated on the 2nd postoperative day and up to 7th postoperative day.To obtain the minute volume (MV), the patient will be instructed to inhale and exhale slowly using the Wright ® ventilometer (British Oxygen Company, London, England).
Forced expiratory volume in the first second (FEV1)It will be evaluated on the 2nd postoperative day and up to 7th postoperative day.It will be evaluated as recommended by the American Thoracic Society and European Respiratory Society (2006) and based on reproducibility and acceptability criteria, three maneuvers will be performed (variability \<5%) and considered the best curve for the study.
Heart rateIt will be evaluated on the 2nd postoperative day and up to 7th postoperative day. This variable will also be measured before and after the first and last BS session.It will be evaluated with portable pulse oximeter.
Peak expiratory flow (PEF)It will be evaluated on the 2nd postoperative day and up to 7th postoperative day.It will be evaluated as recommended by the American Thoracic Society and European Respiratory Society (2006) and based on reproducibility and acceptability criteria, three maneuvers will be performed (variability \<5%) and considered the best curve for the study.
Forced expiratory flow between 25 and 75% of the curve of FVC (FEF25-75)It will be evaluated on the 2nd postoperative day and up to 7th postoperative day.It will be evaluated as recommended by the American Thoracic Society and European Respiratory Society (2006) and based on reproducibility and acceptability criteria, three maneuvers will be performed (variability \<5%) and considered the best curve for the study.
Respiratory muscle strengthThese will be evaluated on the 2nd postoperative day and up to 7th postoperative day.The maximal inspiratory and expiratory pressures will be evaluated with manovacuometer.
Degree of dyspneaIt will be evaluated before and after the application of the BS technique (therefore, only in GBS) on the 2nd postoperative day and up to 7th postoperative day.It will be evaluated using the modified Borg Scale, a vertical scale quantified from 0 to 10. Zero represents no symptoms and 10 represents the maximum of symptoms.
Rates of signs of respiratory discomfort (dizziness, tachypnea, sweating, use accessory musculature)These will be evaluated before and after the application of the BS technique (therefore, only in GBS) on the 2nd postoperative day and up to 7th postoperative day.Evaluated through clinical inspection.
Rates of gastrointestinal symptoms (pain abdominal, nausea, vomiting)These will be evaluated before and after the application of the BS technique (therefore, only in GBS) on the 2nd postoperative day and up to 7th postoperative day.Evaluated through clinical inspection.
FEV1 / FVC ratio (FEV1 / FVC)It will be evaluated on the 2nd postoperative day and up to 7th postoperative day.It will be evaluated as recommended by the American Thoracic Society and European Respiratory Society (2006) and based on reproducibility and acceptability criteria, three maneuvers will be performed (variability \<5%) and considered the best curve for the study.
Respiratory rateIt will be evaluated on the 2nd postoperative day and up to 7th postoperative day. This variable will also be measured before and after the first and last BS session.The respiratory rate will be measured by the movements of the rib cage during respiratory cycles performed in one minute.

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026